Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Vorinostat × 1 year × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Brain Neoplasms 3 Recurrence 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Glioblastoma 2 Breast Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Ototoxicity 1 Oligodendroglioma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Docetaxel 5 Radiation 4 Oxaliplatin 4 Neoadjuvant Therapy 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡